Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 050641
Company: CHARTWELL RX
Company: CHARTWELL RX
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| MONODOX | DOXYCYCLINE | EQ 100MG BASE | CAPSULE;ORAL | Prescription | AB | Yes | No |
| MONODOX | DOXYCYCLINE | EQ 50MG BASE | CAPSULE;ORAL | Prescription | AB | Yes | No |
| MONODOX | DOXYCYCLINE | EQ 75MG BASE | CAPSULE;ORAL | Prescription | AB | Yes | No |
| MONODOX | DOXYCYCLINE | EQ 150MG BASE | CAPSULE;ORAL | Prescription | AB | Yes | No |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 03/31/2025 | SUPPL-34 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050641s034lbl.pdf | |
| 05/08/2024 | SUPPL-33 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050641s033lbl.pdf | |
| 02/17/2022 | SUPPL-32 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050641Orig1s032lbl.pdf | |
| 04/03/2017 | SUPPL-29 | Labeling-Package Insert | Label (PDF) | Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050641s029lbl.pdf |
| 10/11/2013 | SUPPL-27 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050641s027lbl.pdf | |
| 01/11/2012 | SUPPL-18 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050641s018lbl.pdf | |
| 03/08/2011 | SUPPL-26 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/050641s026lbl.pdf | |
| 12/20/2007 | SUPPL-14 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050641s014lbl.pdf |